Literature DB >> 22810052

Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols.

Nathan Perlis1, Polat Turker, Peter J Bostrom, Cynthia Kuk, Tuomas Mirtti, Girish Kulkarni, Neil E Fleshner, Michael A S Jewett, Antonio Finelli, Alexandre R Zlotta.   

Abstract

PURPOSE: To examine which patient-related and tumour-related characteristics predict upper urinary tract recurrence (UUTR) and urethral recurrence (UR) of bladder cancer post-radical cystectomy (RC). Secondary objective is to evaluate whether or not recurrence patterns are similar between two centres with different post-RC follow-up (F/U) protocols.
METHODS: A retrospective cohort study of 574 consecutive patients undergoing radical cystectomy for urothelial carcinoma of the bladder at two tertiary centres was performed. Clinicopathological factors associated with bladder cancer recurrence and patient-related outcomes, including time to recurrence and death, were collected. Risk factors for recurrences were examined using univariate and multivariable regression analyses. Likelihood of recurrence, time to recurrence, and survival were compared.
RESULTS: There was a 3.7 % risk of UUTR (21/574) and a 3.6 % risk of UR (18/503) for the combined cohort at a median F/U of 45 months. When controlling for the effects of all variables modelled, female gender was a significant risk factor for UUT recurrence (OR 3.2, 95 % CI 1.0-9.5, p = 0.03) and prostatic urethral involvement was a significant risk factor for urethral recurrence (OR 7.8, 95 % CI 2.2-27.6, p = 0.001). UUTR were similar (p = 0.82) between Turku (8/205) and Toronto (12/369). Urethral recurrences trended (p = 0.06) towards being more common in Turku (9/151, 6.0 %) versus Toronto (9/352, 2.6 %), but no difference in overall survival was demonstrated between sites.
CONCLUSION: The frequency of UUT and urethral recurrences post-cystectomy is relatively low and remained stable for the past 15 years. The ideal F/U protocol to maximize patient-survival remains unknown.

Entities:  

Mesh:

Year:  2012        PMID: 22810052     DOI: 10.1007/s00345-012-0905-2

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  13 in total

1.  Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.

Authors:  William Tran; Angel M Serio; Ganesh V Raj; Guido Dalbagni; Andrew J Vickers; Bernard H Bochner; Harry Herr; S Machele Donat
Journal:  J Urol       Date:  2007-11-13       Impact factor: 7.450

Review 2.  Development and progression of urothelial carcinoma.

Authors:  Tadao Kakizoe
Journal:  Cancer Sci       Date:  2006-07-04       Impact factor: 6.716

3.  Urethral recurrence following radical cystectomy.

Authors:  S W Hardeman; M S Soloway
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

4.  Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma.

Authors:  Eric C Umbreit; Paul L Crispen; Mark S Shimko; Sara A Farmer; Michael L Blute; Igor Frank
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

5.  Risk factors and outcomes of urethral recurrence following radical cystectomy.

Authors:  Stephen A Boorjian; Simon P Kim; Christopher J Weight; John C Cheville; Prabin Thapa; Igor Frank
Journal:  Eur Urol       Date:  2011-08-22       Impact factor: 20.096

6.  Upper tract tumors in patients with primary bladder cancer followed for 15 years.

Authors:  H W Herr; M S Cookson; S M Soloway
Journal:  J Urol       Date:  1996-10       Impact factor: 7.450

7.  Oncological followup after radical cystectomy for bladder cancer-is there any benefit?

Authors:  Bjoern G Volkmer; Rainer Kuefer; Georg C Bartsch; Kilian Gust; Richard E Hautmann
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

8.  Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?

Authors:  Bjoern G Volkmer; Thomas Schnoeller; Rainer Kuefer; Kilian Gust; Florian Finter; Richard E Hautmann
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

9.  Clonal origin of bladder cancer.

Authors:  D Sidransky; P Frost; A Von Eschenbach; R Oyasu; A C Preisinger; B Vogelstein
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

10.  Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.

Authors:  Jonathan L Wright; James Hotaling; Michael P Porter
Journal:  J Urol       Date:  2009-01-16       Impact factor: 7.450

View more
  9 in total

1.  [Follow-up surveillance of muscle-invasive urinary bladder cancer after curative treatment].

Authors:  G B Schulz; C G Stief; B Schlenker
Journal:  Urologe A       Date:  2019-09       Impact factor: 0.639

Review 2.  Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.

Authors:  Georgios Gakis; Peter C Black; Bernard H Bochner; Stephen A Boorjian; Arnulf Stenzl; George N Thalmann; Wassim Kassouf
Journal:  Eur Urol       Date:  2016-10-06       Impact factor: 20.096

3.  Risk Factors for Urethral Recurrence in Men After Radical Cystectomy with Orthotopic Urinary Diversion for Urothelial Carcinoma: A Retrospective Cohort Study.

Authors:  Dong Hyeon Lee; Wan Song
Journal:  Cancer Manag Res       Date:  2020-08-03       Impact factor: 3.989

4.  A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph node.

Authors:  Sung Han Kim; Hyung-Kook Yang; Jung Hoon Lee; Eun-Sik Lee
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

5.  Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.

Authors:  Xinyuan Li; Wuwan Wang; Gongmin Zhu; Weiyang He; Xin Gou
Journal:  Oncotarget       Date:  2017-12-19

6.  Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?

Authors:  Günter Niegisch; Christina Hulsbergen-van de Kaa; Martine Ploeg; Kees Hendricksen; J Alfred Witjes
Journal:  Bladder Cancer       Date:  2015-04-30

7.  Risk factors for upper tract urothelial recurrence following local excision of bladder cancer.

Authors:  Ning Lin; Yu-Peng Wu; Yun-Zhi Lin; Xuan Tao; Shao-Hao Chen; Zhi-Bin Ke; Yong Wei; Qing-Shui Zheng; Xue-Yi Xue; Ning Xu
Journal:  Cancer Med       Date:  2018-06-28       Impact factor: 4.452

8.  Robot-Assisted Totally Intracorporeal Resection of Cutaneous Ureterostomy Tumor and Ileal Conduit Surgery: A Rare Case Report.

Authors:  Lingkai Cai; Juntao Zhuang; Qiang Cao; Baorui Yuan; Qikai Wu; Kai Li; Jie Han; Hao Yu; JianCheng Lv; Dexiang Feng; Peikun Liu; Ruixi Yu; Pengchao Li; Xiao Yang; Qiang Lu
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

9.  Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer.

Authors:  Marie C Hupe; Lukas Dormayer; Tomasz Ozimek; Julian P Struck; Martin J P Hennig; Melanie Klee; Christoph A J von Klot; Markus A Kuczyk; Axel S Merseburger; Mario W Kramer
Journal:  BMC Cancer       Date:  2020-02-21       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.